Juno touts latest cancer drug results after rivals win FDA approval
November 01, 2017 at 20:04 PM EDT
Juno Therapeutics announced new cancer trial results that could help the drugmaker leapfrog key competitors in the rapidly emerging cancer immunotherapy industry.
